Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels

被引:125
作者
Satriano, J
Matsufuji, S
Murakami, Y
Lortie, MJ
Schwartz, D
Kelly, CJ
Hayashi, S
Blantz, RC
机构
[1] Univ Calif San Diego, Vet Affairs Med Ctr, Div Nephrol Hypertens, Dept Med, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Program Mol Pathol, Dept Med, San Diego, CA 92161 USA
[3] Jikei Univ, Sch Med, Dept Biochem 2, Minato Ku, Tokyo 105, Japan
关键词
D O I
10.1074/jbc.273.25.15313
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyamines are required for entry and progression of the cell cycle. As such, augmentation of polyamine levels is essential for cellular transformation. Polyamines are autoregulated through induction of antizyme, which represses both the rate-limiting polyamine biosynthetic enzyme ornithine decarboxylase and cellular polyamine transport. In the present study we demonstrate that agmatine, a metabolite of arginine via arginine decarboxylase (an arginine pathway distinct from that of the classical polyamines), also serves the dual regulatory functions of suppressing polyamine biosynthesis and cellular polyamine uptake through induction of antizyme, The capacity of agmatine to induce antizyme is demonstrated by: (a) an agmatine-dependent translational frameshift of antizyme mRNA to produce a full-length protein and (b) suppression of agmatine-dependent inhibitory activity by either anti-antizyme IgG or antizyme inhibitor. Furthermore, agmatine administration depletes intracellular polyamine levels to suppress cellular proliferation in a transformed cell lime. This suppression is reversible with polyamine supplementation. We propose a novel regulatory pathway in which agmatine acts as an antiproliferative molecule and potential tumor suppressor by restricting the cellular polyamine supply required to support growth.
引用
收藏
页码:15313 / 15316
页数:4
相关论文
共 28 条
[11]  
LAULAJAINEN T, 1993, LAB INVEST, V69, P183
[12]   AGMATINE - AN ENDOGENOUS CLONIDINE-DISPLACING SUBSTANCE IN THE BRAIN [J].
LI, G ;
REGUNATHAN, S ;
BARROW, CJ ;
ESHRAGHI, J ;
COOPER, R ;
REIS, DJ .
SCIENCE, 1994, 263 (5149) :966-969
[13]   CELL-CYCLE PHASE-DEPENDENT INDUCTION OF ORNITHINE DECARBOXYLASE-ANTIZYME [J].
LINDEN, M ;
ANEHUS, S ;
LANGSTROM, E ;
BALDETORP, B ;
HEBY, O .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 125 (02) :273-276
[14]   AUTOREGULATORY FRAMESHIFTING IN DECODING MAMMALIAN ORNITHINE DECARBOXYLASE ANTIZYME [J].
MATSUFUJI, S ;
MATSUFUJI, T ;
MIYAZAKI, Y ;
MURAKAMI, Y ;
ATKINS, JF ;
GESTELAND, RF ;
HAYASHI, S .
CELL, 1995, 80 (01) :51-60
[15]   FEEDBACK REPRESSION OI POLYAMINE TRANSPORT IS MEDIATED BY ANTIZYME IN MAMMALIAN TISSUE-CULTURE CELLS [J].
MITCHELL, JLA ;
JUDD, GG ;
BAREYALLEYSER, A ;
LING, SY .
BIOCHEMICAL JOURNAL, 1994, 299 :19-22
[16]  
MOULINOUX JP, 1991, CELL MOL BIOL, V37, P773
[17]   INVOLVEMENT OF THE PROTEASOME AND ANTIZYME IN ORNITHINE DECARBOXYLASE DEGRADATION BY A RETICULOCYTE LYSATE [J].
MURAKAMI, Y ;
MATSUFUJI, S ;
TANAKA, K ;
ICHIHARA, A ;
HAYASHI, S .
BIOCHEMICAL JOURNAL, 1993, 295 :305-308
[18]  
Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340
[19]   ORNITHINE DECARBOXYLASE IS A MEDIATOR OF C-MYC-INDUCED APOPTOSIS [J].
PACKHAM, G ;
CLEVELAND, JL .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :5741-5747
[20]  
PEGG AE, 1988, CANCER RES, V48, P759